Amyloid-β Oligomers Interact with Neurexin and Diminish Neurexin-mediated Excitatory Presynaptic Organization

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Naito, Yusuke ^a,b   Tanabe, Yuko ^a   Lee, Alfred Kihoon ^a,b   Hamel, Edith ^c   Takahashi, Hideto ^a,b,d  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; LRRTM2 PROTEIN, HUMAN; MEMBRANE PROTEIN; NERVE CELL ADHESION MOLECULE; NERVE PROTEIN; PROTEIN BINDING;

ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; ANIMAL; AXON; CELL CULTURE; CELL LINE; CHEMISTRY; CHLOROCEBUS AETHIOPS; CV-1 CELL LINE; DISEASE MODEL; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; MOUSE; NERVE ENDING; PATHOLOGY; PHYSIOLOGY; PROTEIN DOMAIN; PROTEIN MULTIMERIZATION; SYNAPTIC POTENTIAL;

ALTERNATIVE SPLICING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; AXONS; CELL ADHESION MOLECULES, NEURONAL; CELL LINE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HUMANS; MEMBRANE PROTEINS; MICE; NERVE TISSUE PROTEINS; PRESYNAPTIC TERMINALS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; SYNAPTIC POTENTIALS;

EID: 85012303416     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep42548     Document Type: Article

References (60)

1. Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356 (2002).
2. Holtzman, D. M., Morris, J. C. & Goate, A. M. Alzheimer's disease: the challenge of the second century. Sci Transl Med 3, 77sr71 (2011).
3. Scheff, S. W. & Price, D. A. Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiol Aging 24, 1029-1046 (2003).
4. Sheng, M., Sabatini, B. L. & Sudhof, T. C. Synapses and Alzheimer's disease. Cold Spring Harb Perspect Biol 4, a005777 (2012).
5. Selkoe, D. J. Alzheimer's disease is a synaptic failure. Science 298, 789-791 (2002).
6. Mucke, L. & Selkoe, D. J. Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. Cold Spring Harb Perspect Med 2, a006338 (2012).
7. Snyder, E. M. et al. Regulation of NMDA receptor trafficking by amyloid-β. Nat Neurosci 8, 1051-1058 (2005).
8. Roselli, F. et al. Soluble β-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses. J Neurosci 25, 11061-11070 (2005).
9. Calabrese, B. et al. Rapid, concurrent alterations in pre-and postsynaptic structure induced by naturally-secreted amyloid-β protein. Mol Cell Neurosci 35, 183-193 (2007).
10. Roselli, F., Hutzler, P., Wegerich, Y., Livrea, P. & Almeida, O. F. Disassembly of shank and homer synaptic clusters is driven by soluble β-amyloid1-40 through divergent NMDAR-dependent signalling pathways. PLoS One 4, e6011 (2009).
11. Russell, C. L. et al. Amyloid-β acts as a regulator of neurotransmitter release disrupting the interaction between synaptophysin and VAMP2. PLoS One 7, e43201 (2012).
12. Ripoli, C. et al. Effects of different amyloid β-protein analogues on synaptic function. Neurobiol Aging 34, 1032-1044 (2013).
13. Shrestha, B. R. et al. Amyloid β peptide adversely affects spine number and motility in hippocampal neurons. Mol Cell Neurosci 33, 274-282 (2006).
14. Wei, W. et al. Amyloid beta from axons and dendrites reduces local spine number and plasticity. Nat Neurosci 13, 190-196 (2010).
15. Shankar, G. M. et al. Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDAtype glutamate receptor-dependent signaling pathway. J Neurosci 27, 2866-2875 (2007).
16. Pozueta, J. et al. Caspase-2 is required for dendritic spine and behavioural alterations in J20 APP transgenic mice. Nat Commun 4, 1939 (2013).
17. Shankar, G. M. et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14, 837-842 (2008).
18. Sudhof, T. C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455, 903-911 (2008).
19. Craig, A. M. & Kang, Y. Neurexin-neuroligin signaling in synapse development. Curr Opin Neurobiol 17, 43-52 (2007).
20. Siddiqui, T. J. & Craig, A. M. Synaptic organizing complexes. Curr Opin Neurobiol 21, 132-143 (2011).
21. Bemben, M. A., Shipman, S. L., Nicoll, R. A. & Roche, K. W. The cellular and molecular landscape of neuroligins. Trends Neurosci 38, 496-505 (2015).
22. Takahashi, H. & Craig, A. M. Protein tyrosine phosphatases PTPδ, PTPσ, and LAR: presynaptic hubs for synapse organization. Trends Neurosci 36, 522-534 (2013).
23. Takahashi, H. et al. Postsynaptic TrkC and presynaptic PTPδ function as a bidirectional excitatory synaptic organizing complex. Neuron 69, 287-303 (2011).
24. Takahashi, H. et al. Selective control of inhibitory synapse development by Slitrk3-PTPδ trans-synaptic interaction. Nat Neurosci 15, 389-398 (2012).
25. Yim, Y. S. et al. Slitrks control excitatory and inhibitory synapse formation with LAR receptor protein tyrosine phosphatases. Proc Natl Acad Sci USA 110, 4057-4062 (2013).
26. Linhoff, M. W. et al. An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizers. Neuron 61, 734-749 (2009).
27. de Wit, J. et al. LRRTM2 interacts with Neurexin1 and regulates excitatory synapse formation. Neuron 64, 799-806 (2009).
28. Ko, J., Fuccillo, M. V., Malenka, R. C. & Sudhof, T. C. LRRTM2 functions as a neurexin ligand in promoting excitatory synapse formation. Neuron 64, 791-798 (2009).
29. Siddiqui, T. J., Pancaroglu, R., Kang, Y., Rooyakkers, A. & Craig, A. M. LRRTMs and neuroligins bind neurexins with a differential code to cooperate in glutamate synapse development. J Neurosci 30, 7495-7506 (2010).
30. Um, J. W. et al. LRRTM3 Regulates Excitatory Synapse Development through Alternative Splicing and Neurexin Binding. Cell Rep 14, 808-822 (2016).
31. Pettem, K. L. et al. The Specific α-Neurexin Interactor Calsyntenin-3 Promotes Excitatory and Inhibitory Synapse Development. Neuron 80, 113-128 (2013).
32. Matsuda, K. et al. Cbln1 is a ligand for an orphan glutamate receptor δ2, a bidirectional synapse organizer. Science 328, 363-368 (2010).
33. Matsuda, K. & Yuzaki, M. Cbln family proteins promote synapse formation by regulating distinct neurexin signaling pathways in various brain regions. Eur J Neurosci 33, 1447-1461 (2011).
34. Uemura, T. et al. Trans-synaptic interaction of GluRδ2 and Neurexin through Cbln1 mediates synapse formation in the cerebellum. Cell 141, 1068-1079 (2010).
35. Woo, J. et al. Trans-synaptic adhesion between NGL-3 and LAR regulates the formation of excitatory synapses. Nat Neurosci 12, 428-437 (2009).
36. Kwon, S. K., Woo, J., Kim, S. Y., Kim, H. & Kim, E. Trans-synaptic adhesions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases LAR, protein-tyrosine phosphataseδ (PTPδ), and PTPσ via specific domains regulate excitatory synapse formation. J Biol Chem 285, 13966-13978 (2010).
37. Valnegri, P. et al. The X-linked intellectual disability protein IL1RAPL1 regulates excitatory synapse formation by binding PTPδ and RhoGAP2. Hum Mol Genet 20, 4797-4809 (2011).
38. Yoshida, T. et al. IL-1 receptor accessory protein-like 1 associated with mental retardation and autism mediates synapse formation by trans-synaptic interaction with protein tyrosine phosphatase? J Neurosci 31, 13485-13499 (2011).
39. Yoshida, T. et al. Interleukin-1 receptor accessory protein organizes neuronal synaptogenesis as a cell adhesion molecule. J Neurosci 32, 2588-2600 (2012).
40. Saura, C. A., Servian-Morilla, E. & Scholl, F. G. Presenilin/γ-secretase regulates neurexin processing at synapses. PLoS One 6, e19430 (2011).
41. Bot, N., Schweizer, C., Ben Halima, S. & Fraering, P. C. Processing of the synaptic cell adhesion molecule neurexin-3β by Alzheimer disease α-and γ-secretases. J Biol Chem 286, 2762-2773 (2011).
42. Haapasalo, A. et al. Presenilin/γ-secretase-mediated cleavage regulates association of leukocyte-common antigen-related (LAR) receptor tyrosine phosphatase with β-catenin. J Biol Chem 282, 9063-9072 (2007).
43. Viswanathan, J. et al. Ubiquilin-1 modulates γ-secretase-mediated ϵ-site cleavage in neuronal cells. Biochemistry 52, 3899-3912 (2013).
44. Suzuki, K. et al. Activity-dependent proteolytic cleavage of neuroligin-1. Neuron 76, 410-422 (2012).
45. Dinamarca, M. C., Weinstein, D., Monasterio, O. & Inestrosa, N. C. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease? Biochemistry 50, 8127-8137 (2011).
46. Kim, T. et al. Human LilrB2 is a beta-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model. Science 341, 1399-1404 (2013).
47. Lauren, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W. & Strittmatter, S. M. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers. Nature 457, 1128-1132 (2009).
48. Reissner, C., Runkel, F. & Missler, M. Neurexins. Genome biology 14, 213 (2013).
49. Graf, E. R., Kang, Y., Hauner, A. M. & Craig, A. M. Structure function and splice site analysis of the synaptogenic activity of the neurexin-1β LNS domain. J Neurosci 26, 4256-4265 (2006).
50. Miesenbock, G., De Angelis, D. A. & Rothman, J. E. Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins. Nature 394, 192-195 (1998).
51. Mucke, L. et al. High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20, 4050-4058 (2000).
52. Um, J. W. et al. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer Aβ oligomer bound to cellular prion protein. Neuron 79, 887-902 (2013).
53. Hu, N. W. et al. mGlu5 receptors and cellular prion protein mediate amyloid-β-facilitated synaptic long-term depression in vivo. Nat Commun 5, 3374 (2014).
54. Cisse, M. et al. Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature 469, 47-52 (2011).
55. Scheff, S. W., DeKosky, S. T. & Price, D. A. Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol Aging 11, 29-37 (1990).
56. 2+ channels to synaptic vesicle exocytosis. Nature 423, 939-948 (2003).
57. Anderson, G. R. et al. β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. Cell 162, 593-606 (2015).
58. Abramov, E. et al. Amyloid-β as a positive endogenous regulator of release probability at hippocampal synapses. Nat Neurosci 12, 1567-1576 (2009).
59. Fuccillo, M. V. et al. Single-Cell mRNA Profiling Reveals Cell-Type-Specific Expression of Neurexin Isoforms. Neuron 87, 326-340 (2015).
60. Caetano, F. A. et al. Amyloid-beta oligomers increase the localization of prion protein at the cell surface. J Neurochem 117, 538-553 (2011).